CH601263A5 - - Google Patents

Info

Publication number
CH601263A5
CH601263A5 CH1404974A CH1404974A CH601263A5 CH 601263 A5 CH601263 A5 CH 601263A5 CH 1404974 A CH1404974 A CH 1404974A CH 1404974 A CH1404974 A CH 1404974A CH 601263 A5 CH601263 A5 CH 601263A5
Authority
CH
Switzerland
Application number
CH1404974A
Inventor
Andre Dr Szente
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Priority to CH1404974A priority Critical patent/CH601263A5/xx
Priority to US05/622,291 priority patent/US4031078A/en
Priority to DE19752546614 priority patent/DE2546614A1/de
Priority to JP50124477A priority patent/JPS5165787A/ja
Priority to FR7531799A priority patent/FR2288523A1/fr
Priority to GB4298175A priority patent/GB1474305A/en
Publication of CH601263A5 publication Critical patent/CH601263A5/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D243/00—Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms
    • C07D243/06—Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms having the nitrogen atoms in positions 1 and 4
    • C07D243/10—Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms having the nitrogen atoms in positions 1 and 4 condensed with carbocyclic rings or ring systems
    • C07D243/14—1,4-Benzodiazepines; Hydrogenated 1,4-benzodiazepines
    • C07D243/16—1,4-Benzodiazepines; Hydrogenated 1,4-benzodiazepines substituted in position 5 by aryl radicals
    • C07D243/18—1,4-Benzodiazepines; Hydrogenated 1,4-benzodiazepines substituted in position 5 by aryl radicals substituted in position 2 by nitrogen, oxygen or sulfur atoms
    • C07D243/24—Oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C271/00—Derivatives of carbamic acids, i.e. compounds containing any of the groups, the nitrogen atom not being part of nitro or nitroso groups
    • C07C271/06—Esters of carbamic acids
    • C07C271/08—Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms
    • C07C271/10—Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms with the nitrogen atoms of the carbamate groups bound to hydrogen atoms or to acyclic carbon atoms
    • C07C271/22—Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms with the nitrogen atoms of the carbamate groups bound to hydrogen atoms or to acyclic carbon atoms to carbon atoms of hydrocarbon radicals substituted by carboxyl groups
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D243/00—Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms
    • C07D243/06—Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms having the nitrogen atoms in positions 1 and 4
    • C07D243/10—Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms having the nitrogen atoms in positions 1 and 4 condensed with carbocyclic rings or ring systems
    • C07D243/14—1,4-Benzodiazepines; Hydrogenated 1,4-benzodiazepines
    • C07D243/16—1,4-Benzodiazepines; Hydrogenated 1,4-benzodiazepines substituted in position 5 by aryl radicals
    • C07D243/18—1,4-Benzodiazepines; Hydrogenated 1,4-benzodiazepines substituted in position 5 by aryl radicals substituted in position 2 by nitrogen, oxygen or sulfur atoms
    • C07D243/22—Sulfur atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
CH1404974A 1974-10-21 1974-10-21 CH601263A5 (fr)

Priority Applications (6)

Application Number Priority Date Filing Date Title
CH1404974A CH601263A5 (fr) 1974-10-21 1974-10-21
US05/622,291 US4031078A (en) 1974-10-21 1975-10-14 Benzodiazepine derivatives
DE19752546614 DE2546614A1 (de) 1974-10-21 1975-10-17 Benzodiazepin-derivate
JP50124477A JPS5165787A (fr) 1974-10-21 1975-10-17
FR7531799A FR2288523A1 (fr) 1974-10-21 1975-10-17 Derives de benzodiazepine
GB4298175A GB1474305A (en) 1974-10-21 1975-10-20 Benzodiazepine derivatives

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CH1404974A CH601263A5 (fr) 1974-10-21 1974-10-21

Publications (1)

Publication Number Publication Date
CH601263A5 true CH601263A5 (fr) 1978-06-30

Family

ID=4397516

Family Applications (1)

Application Number Title Priority Date Filing Date
CH1404974A CH601263A5 (fr) 1974-10-21 1974-10-21

Country Status (6)

Country Link
US (1) US4031078A (fr)
JP (1) JPS5165787A (fr)
CH (1) CH601263A5 (fr)
DE (1) DE2546614A1 (fr)
FR (1) FR2288523A1 (fr)
GB (1) GB1474305A (fr)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0253571A1 (fr) * 1986-07-14 1988-01-20 Merck & Co. Inc. Procédé de dédoublement et de racémisation d'amines à l'aide d'alpha-hydrogènes acides

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3535253A1 (fr) 2016-11-01 2019-09-11 H. Hoffnabb-La Roche Ag 1,3-dihydro -1,4-benzodiazépine-2-thiones pour le traitement de maladies liées au snc

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3121076A (en) * 1964-02-11 Benzodiazepinones and processes
NL126389C (fr) * 1962-07-10

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0253571A1 (fr) * 1986-07-14 1988-01-20 Merck & Co. Inc. Procédé de dédoublement et de racémisation d'amines à l'aide d'alpha-hydrogènes acides

Also Published As

Publication number Publication date
JPS5165787A (fr) 1976-06-07
US4031078A (en) 1977-06-21
FR2288523A1 (fr) 1976-05-21
GB1474305A (en) 1977-05-25
DE2546614A1 (de) 1976-04-22
FR2288523B1 (fr) 1980-05-30

Similar Documents

Publication Publication Date Title
FR2290094B1 (fr)
DK142634C (fr)
JPS50119293A (fr)
JPS50114385A (fr)
JPS50132696A (fr)
FR2271134B1 (fr)
FR2284915B1 (fr)
FR2261469B3 (fr)
FR2291592B3 (fr)
FR2288523B1 (fr)
FR2288524B1 (fr)
AR199073A1 (fr)
JPS50137693A (fr)
JPS50127519U (fr)
JPS50105332U (fr)
JPS50115534U (fr)
BE829579A (fr)
CH577885A5 (fr)
BG20148A1 (fr)
BG19932A1 (fr)
BG20706A1 (fr)
BG20739A1 (fr)
BG19905A1 (fr)
BG19619A1 (fr)
BG20921A1 (fr)

Legal Events

Date Code Title Description
PL Patent ceased